Trametinib in Patients With Advanced Neurofibromatosis Type 1 (NF1)-Mutant Non-small Cell Lung Cancer

NCT03232892 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Low Accrual

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: Trametinib

Sponsor

University of California, San Francisco

Collaborators

[object Object]
[object Object]